Intracavitary Brachytherapy Device for Insertion in a Body Cavity and Methods of Use Thereof

• US 20140121445A1
• Filed: 10/28/2013
• Published: 05/01/2014
• Est. Priority Date: 10/28/2012
• Status: Abandoned Application

• Current Assignee: PF Biomedical Solutions LLC
• Original Assignee: PF Biomedical Solutions LLC
• Inventors: Fontenot, Jonas D., Price, Michael J.
• Application Number:
  US14/065,408
• Publication Number:
  US 20140121445A1
• Time in Patent Office: Days
• US Class Current: 600/6
• CPC Class Codes: A61B 1/00087 Tools A61B17/00234 takes precedence
• CPC Class Codes: A61B 1/05 characterised by the image sensor, e.g. camera, being in the distal end portion
• CPC Class Codes: A61B 1/303 for the vagina, i.e. vaginoscopes
• CPC Class Codes: A61N 5/1016 Gynaecological radiation therapy

Abstract

A brachytherapy application device is described, which includes a tandem having a transparent region at its front end, and which is coupled with a fiber-optic illumination means and endoscope. This improved tandem assembly allows the user to guide the tandem into the uterus of a patient in a safer, more reproducible manner with the reduction in occurrence of uterine perforation during tandem advancement and placement.

Claims

1. An applicator apparatus for radioactive therapy of uterine cervix carcinoma, the apparatus comprising:

a tubular tandem having a longitudinally extending finite tandem-length defined by a closed lead-end for insertion through the uterine cervix and a closeable trail-end permitting charging of radioactive material into the tandem leadward portion, the tandem trailward length portion lying substantially parallel to a sagittal-plane;

wherein the lead end of the tandem comprises;

at least one image sensor disposed within the tandem;

one or more discrete optical channels disposed within the tandem; and

,

a light transmitting means disposed within the interior of the tandem.

2. The apparatus of claim 1, wherein a least a portion of the lead-end of the tandem is transparent or semi-transparent.

3. The apparatus of claim 1, further comprising two ovoidal assemblies each comprising an elongate tubular arm having a directionally longitudinal finite arm-length less than the tandem-length and defined by a closed leading-end and a closeable trailing-end permitting charging of radioactive material into the arm lead-length portion,

each ovoidal assembly at the arm trail-length portion being removably and/or pivotably attachable to the adapter member whereby the leading-end of the respective arms is free to move laterally away from the tandem leadward length portion.

5. The method of claim 4, wherein the method of treating carcinoma in a patient includes delivering a radiation therapy to a gynecological tissue in a subject in need thereof using the apparatus of claim 1.

6. The method of claim 5, wherein the radiation therapy is delivered by a radiation source.

7. The method of claim 6, wherein the radiation source comprises a radioactive liquid, an x-ray source, a radiation seed, or combinations thereof.

8. The method of claim 6, wherein the radiation source comprises radionuclides selected from the group consisting of cesium, iridium, iodine, cobalt, palladium, strontium, yttrium, gold, ruthenium, californium, and combinations thereof.

9. The method of claim 6, wherein the radiation source is loaded into the central catheter, at least one peripheral catheter, or a combination thereof, using an afterloader.

10. The method of claim 6, wherein the radiation source is used to treat a gynecological cancer.

11. The method of claim 10, wherein the gynecological cancer is selected from the group consisting of cervical cancer, endometrial cancer, uterine cancer, ovarian cancer, and vaginal cancer.

12. The method of claim 5, wherein the target tissue is the uterus, the cervix, or the vaginal cuff.

4. A method of treating carcinoma in a patient in need thereof, the method comprising the steps of:

inserting an assembly comprising a tubular tandem and first and second tubular side assemblies through the vaginal orifice of the patient with the tandem extending into the uterus and the first and second side assemblies being positioned against the vaginal wall; and

emitting radiation from at least one of the tubular tandem and first and second tubular side assemblies;

wherein the step of inserting the tubular tandem includes the steps of integrally associating the lead end of the tandem with an endoscope and illumination means for illuminating the area immediately in front of the lead end of the tandem and activating the endoscope and illumination means prior to or after insertion of the assembly through the vaginal orifice.

13. A system for delivering radiation therapy to a gynecological tissue, the system comprising:

one or more gynecological brachytherapy applicators, the brachytherapy applicators comprising a tubular tandem having a longitudinally extending finite tandem-length defined by a closed lead-end for insertion through the uterine cervix and a closeable trail-end permitting charging of radioactive material into the tandem leadward portion, the tandem trailward length portion lying substantially parallel to a sagittal-plane;

wherein the lead end of the tandem comprises;

at least one image sensor disposed within the tandem;

one or more discrete optical channels disposed within the tandem; and

,

a light transmitting means disposed within the interior of the tandem;

one or more removable sheaths for housing the one or more brachytherapy applicators during advancement to the target tissue;

one or more removable handles for positioning or repositioning the one or more brachytherapy applicators; and

instructions for using the one or more brachytherapy applicators.

14. The system of claim 13, comprising a plurality of brachytherapy applicators.

15. The system of claim 13, wherein the plurality of brachytherapy applicators vary in length, shape at the distal end, number of peripheral passages and catheters, initial expanded diameter, unexpanded diameter, expanded deployed diameter, or a combination thereof.

16. The system of claim 39, further comprising one or more radiation sources.

17. The system of claim 16, wherein the one or more radiation sources comprise a radioactive liquid, an x-ray source, a radiation seed, or combinations thereof.